Integer (ITGR)

Executive Summary

Integer Holdings Corporation is a leading global medical device outsource manufacturer, providing design, development, and volume production services to top OEMs across cardiac rhythm management, neuromodulation, vascular access, and orthopedics. With a 50-year track record and a market cap of ~$3.2B, the company benefits from secular trends toward outsourcing by medtech firms seeking cost efficiency and faster time-to-market. Integer's comprehensive solutions from concept to production position it as a key partner in high-growth therapeutic areas. The company's financial performance is driven by volume growth from existing programs and new program wins, supported by its global manufacturing footprint. Near-term headwinds include supply chain volatility and customer inventory destocking, but long-term demand for minimally invasive procedures and aging demographics underpin growth. Integer's strong customer relationships and diversified revenue base provide resilience.

Upcoming Catalysts (preview)

• Q3 2026Q3 2026 Earnings Report90% success
• Q3 2026Major New Program Win with Top-Tier OEM40% success
• Q4 2026Capacity Expansion Announcement60% success